The outbreak of Acinetobacter baumannii producing OXA-23 and OXA-51 type carbapenemases in a state hospital

Abstract

Acinetobacter baumannii is non-fermentative gram-negative bacilli which plays an important pathogen especially in intensive care units causing infections and epidemics. Carbapenem resistance often is consisted of OXA-type carbapenemase. In this study, we aimed to determine carbapenem resistance and clonal relationships of A. baumannii isolated from patient and enviromental samples by phenotypic and genotypic methods in 10-bed intensive care unit. Multiplex-PCR method was used to determine the genes of OXA type beta-lactamases (blaOXA) and clonal relations between strains were investigated by pulsed-field gel electrophoresis (PFGE) method. All of the isolates were found to be carbapenem resistant and had the blaOXA-51-like and blaOXA-23-like gene. Also, all of isolates were seen to be 100 % related by PFGE method. As a result, isolates of patients with ventilator-associated pneumonia and isolates survived on ventilator of Intensive Care Unit were found to be 100% clonal associated with PFGE and had same MIC values for imipenem and meropenem. blaOXA-23 and blaOXA-51 genes has been determined all of the isolates. It can be accepted a short-term and small outbreak.

Keywords

• A. baumannii,Outbreak,OXA-23,OXA-51

References

1. Arıkan, A.Ö., 2003. Acinetobacter baumannii izolatlarında antibiyotik direnci: 2002 yılı İbni Sina Hastanesi verileri, Mikrobiyol. Bült. 37, 241-246.
2. Arslan, H., 2014. Acinetobacter moleküler epidemiyolojisi. ANKEM. 28, 71-72.
3. Balcı, M., Bitirgen, M., Kandemir, B., Arıbaş, E.T., Erayman, I., 2010. Antibiotic susceptibility of nosocomial acinetobacter baumannii strains. 24, 28-33.
4. Bergogne-Bérézin, E., Towner, K.J., 1996. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9, 148-165.
5. Durmaz, R., Otlu, B., Koksal, F., Hosoglu, S., Ozturk, R., Ersoy, Y., Aktas, E., Gursoy, N.C., Caliskan, A., 2009. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn. J. Infect. Dis. 62, 372-327.
6. Ertürk, A., Çiçek, A.Ç., Gümüş, A, Cüre, E., Şen, A., Kurt, A., Karagöz, A., Aydoğan, N., Sandallı, C., Durmaz, R., 2014. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units. Ann. Clinic. Microbiol. Antimicrob. 13, 36. doi:10.1186/s12941-014-0036-2.
7. European Commitee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Versions3.1.Available:http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_ table_v_3.1.pdf Accessed 10 May 2014.
8. Gözütok, F., Sarıgüzel, F.M., Çelik, İ., Berk, E., Aydın, B., Güzel, D., 2013. Hastane infeksiyonu etkeni acinetobacter baumannii suşlarının antimikrobiyal direnç oranlarının araştırılması. ANKEM. 27, 7-12.

9. Gökmen, T.G., Güran, M., Benk, I.G., Kızılyıldırım, S., Köksal, F., 2012. Yanık ünitesinde kısa-dönem/uzun-dönem acinetobacter baumannii salgını. Ankem. 26, 120-125.
10. Héritier, C., Poirel, L., Nordmann, P., 2006. Cephalosporinase overexpression as a result of insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12, 123-130. doi: 10.1111/j.1469-0691.2005.01320.x.
11. Inchai, J., Pothirat, C., Bumroongkit, C., Limsukon, A., Khositsakulchai, W., Liwsrisakun, C., 2014. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. J. Inten. Care. 3, 9. doi: 10.1186/ s40560-015-0077-4.
12. Karabay, O., Yahyaoğlu, M., Öğütlü, A., Sandıkçı O, Tuna N, Ceylan S., 2012. Factors associated with mortality in acinetobacter baumannii infected intensive care unit patients. Mikrobiyol. Bul. 46, 335-337.
13. Kohlenberg, A., Brümmer, S., Higgins, P.G., Sohr, D., Piening, B.C., De Grahl., C., Halle, E., Rüden, H., Seifert, H., 2009. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J. Med. Microbiol. 58, 1499-1507. doi: 10.1099/jmm.0.012302-0.
14. Moniri, R., Kheltabadi, Farahani, R., Shajari, G.H., Nazem, Shirazi, M.H., Ghasemi, A., 2010. Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. with emergence of multidrug-resistant strains. Iran. J. Public. Health. 39, 63-68.
15. Naas, T., Poirel, L., Nordmann, P., 2006. Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type β-lactamases in Acinetobacter baumannii. Clinic. Microbiol. Infect. 12, 1236-1240. doi:10.1111/j.1469-0691.2006.01563.x.
16. Nasr, R.A., Attalah, M.F., 2012. Molecular epidemiology of nosocomial acinetobacter baumannii isolates. Nat. Sci. 10, 76-82.
17. Nhu, N.T.K., Lan, N.P.H., Campbell, J.I, Parry, C.M., Thompson, C., Tuyen, H.T., et al., 2014. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J. Med. Microbiol. 63, 1386-1394. doi:10.1099/jmm.0.076646-0.
18. Papp-Wallace, K.M., Endimiani, A., Taracila, M.A, Bonomo, R.A., 2011. Carbapenems: Past, present, and future. Antimicrob. Agents. Chemother. 55, 4943-4960. doi: 10.1128/AAC.00296-11.
19. Peleg, A.Y., Seifert, H., Paterson, D.L., 2008. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-82. doi: 10.1128/CMR.00058-07.
20. Poirel, L., Nordmann, P., 2006. Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836. doi: 10.1111/j.1469-0691.2006.01456.x.
21. Queenan, A,M., Bush, K., 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20, 440-458. doi: 10.1128/ CMR.00001-07 doi: 10.1128/CMR.00001-07.
22. Sabat, A.J., Budimir, A., Nashev, D., Sá-Leão, R., van Dijl, J.M., Laurent, F., Grundmann, H., Friedrich, A.W., 2013. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Eurosurveill. 18, 1-14.
23. Sarı, A.N., Biçmen, M., Gülay, Z., 2013. The first report on the outbreak of OXA-24/40-like carbapenemase-producing Acinetobacter baumannii in Turkey. Jpn. J. Infec.t Dis. 66, 439-442.
24. Taşova, Y., Akgün, Y., Saltoğlu, N., Yılmaz, G., Kara, O., Dündar, I.H., 1999. Nozokomiyal Acinetobacter infeksiyonları. Flora. 4, 170-176.
25. Turton, J.F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M.E., Pitt, T.L., 2006a. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976. doi: 10.1128/ JCM.01021-06.
26. Turton, J.F., Ward, M.E., Woodford, N., Kaufmann, M.E., Pike, R., Livermore, D.M, Pitt, T.L., 2006b. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS. Microbiol. Lett. 258, 72-77. doi: 10.1111/j.1574- 6968.2006.00195.x.
27. Woodford, N., Ellington, M.J., Coelho, J.M., Turton, J.F., Ward, M.E., Brown, S., Amyes, S.G., Livermore, D.M., 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents. 27, 351-353. doi: DOI: 10.1016/j.ijantimicag.2006.01.004